Innavasc Medical, Inc.
Immediate-access hemodialysis arteriovenous graft with self-sealing, needle-resistant design for renal failure patients
- Sector
- Medtech
- Headquarters
- Research Triangle Park, NC
- Founded
- 2013
- Latest Form D
- $1M, Nov 2021
- Total capital
- $12.8M
- Federal grants
- $8.2M
- 8 awards · 2016–2022
- Rank in peer group#68 of 538
- Private capital raised
- $4.6M
- 5 Form D · last Nov 2021
- 60 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 15 pending · first 2021
- Rank in peer group#97 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · A Bullet Proof vascular graft to prevent dialysis access cannulation injury$1.0M
- Private capital raisedForm D · SEC · 5th filing$1M
- Federal grantHealth and Human S · Phase II · A Bullet Proof vascular graft to prevent dialysis access cannulation injury$999K
- Federal grantHealth and Human S · Phase II · A Bullet Proof vascular graft to prevent dialysis access cannulation injury$3M
- Private capital raisedForm D · SEC · 4th filing$415K
- Federal grantNSF · Phase II · SBIR Phase II: Development of a novel graft to provide safe and reliable vascular access for hemodialysis patients$800K
- Federal grantNSF · Phase I · SBIR Phase I: Development of a novel graft to provide safe and reliable vascular access for hemodialysis patients$225K
- Private capital raisedForm D · SEC · 3rd filing$500K
- Private capital raisedForm D · SEC · 2nd filing$2.1M
- Private capital raisedForm D · SEC · 1st filing$520K
Show 3 earlier federal awards
- Federal grantHealth and Human S · Phase II · A Bullet Proof vascular graft to prevent dialysis access cannulation injury$1M
- Federal grantHealth and Human S · Phase II · A Bullet Proof vascular graft to prevent dialysis access cannulation injury$983K
- Federal grantHealth and Human S · Phase I · A Bullet Proof vascular graft to prevent dialysis access cannulation injury$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#68 · top 13%
- Granted patents#97 · top 18%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Shawn GageResearcherExecutive OfficerLinked by 6 patents
- Joseph KnightResearcherExecutive Officer, DirectorLinked by $8.2M in grants as PI
- C Steven DunckerDirectorNamed in SEC Form D filings
- C. Steven DunckerDirectorNamed in SEC Form D filings
- Craig NicholsExecutive OfficerNamed in SEC Form D filings
- Dani BolognesiDirectorNamed in SEC Form D filings
Show all 13 people
- Greg DavisDirectorNamed in SEC Form D filings
- Jeffrey N, LawsonDirectorNamed in SEC Form D filings
- Kenneth GallDirectorNamed in SEC Form D filings
- Roberto Duane MansonExecutive OfficerNamed in SEC Form D filings
- Stephen DunckerDirectorNamed in SEC Form D filings
- William N, StarlingDirectorNamed in SEC Form D filings
- William Starling,Jr.DirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 21- PendingApparatus And Method For Implanting An Arteriovenous GraftUSPTOApplication 19304881
- GrantedApparatus And Method For Implanting An Arteriovenous GraftUSPTOUS 12,414,871
- PendingApparatus And Method For Cannulation Of Vascular Access VesselUSPTOApplication 18428903
Show all 21 patent records
- Apparatus And Method For Implanting An Arteriovenous GraftDec 25, 2025 · Application 19304881Pending
- Apparatus And Method For Implanting An Arteriovenous GraftSep 16, 2025 · US 12,414,871Granted
- Apparatus And Method For Cannulation Of Vascular Access VesselJul 4, 2024 · Application 18428903Pending
- Apparatus And Method For Cannulation Of Vascular Access GraftJun 6, 2024 · Application 18442630Pending
- Apparatus And Method For Cannulation Of Vascular Access GraftMar 26, 2024 · US 11,938,260Granted
- Apparatus And Method For Cannulation Of Vascular Access VesselMar 12, 2024 · US 11,925,782Granted
- Apparatus And Method For Cannulation Of Vascular Access VesselMar 12, 2024 · US 11,925,781Granted
- Apparatus And Method For Implanting An Arteriovenous GraftSep 29, 2022 · Application 17566433Pending
- Vascular Arteriovenous GraftSep 29, 2022 · Application 17566428Pending
- Apparatus And Method For Cannulation Of Vascular Access GraftJul 20, 2021 · US 11,065,377Granted
- Apparatus And Method For Implanting An Arteriovenous GraftJun 29, 2021 · US 11,045,339Granted
- Arteriovenous Graft For Minimizing Arterial Steal And Graft ThrombosisOct 4, 2018 · Application 15941790Pending
- Tunneling Instrument And MethodApplication 63166794Pending
- System And Method For Implanting Arteriovenous GraftApplication 62940438Pending
- Apparatus And Method For Cannulation Of Vascular Access VesselApplication PCTUS2019058665Pending
- Apparatus And Method For Forming A Subcutaneous TunnelApplication 62783187Pending
- Flexible Cannulation Chamber For AvgApplication 63166790Pending
- Arteriovenous Graft For Minimizing Arterial Steal And Graft ThrombosisApplication PCTUS2018025456Pending
- Vascular Arteriovenous GraftApplication PCTUS2021065761Pending
- Apparatus And Method For Cannulation Of Vascular Access GraftApplication PCTUS2018025414Pending
- Apparatus And Method For Implanting An Arteriovenous GraftApplication PCTUS2021065756Pending
Related companies, and why
- Coridea, LLCSimilar federal contract value in Medtech · null in contracts
- ReVivo Medical, LLCSimilar federal contract value in Medtech · null in contracts
- Tenovi Co.Similar federal contract value in Medtech · null in contracts
- DURAMETRIX LLCSimilar federal contract value in Medtech · null in contracts
- ADVANCED IMAGING RESEARCH, INC.Similar federal contract value in Medtech · null in contracts
- CLEAR GENE INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .